KCT0000685
Recruiting
未知
Analysis of Blood and Cerebrospinal Fluids for detecting Genetic mutation, polymorphis and biomarkers in frontotemporal dementia
ConditionsDiseases of the nervous system
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Diseases of the nervous system
- Sponsor
- Pusan National University Hospital
- Enrollment
- 100
- Status
- Recruiting
- Last Updated
- 7 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Knopman et al. 2008 research criteria for FTD
Exclusion Criteria
- •Other neurodegenerative dementia
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The study analyzing blood and cerebrospinal fluids from the patients with early onset Alzheimer disease to discover causative factors and biomarkersDiseases of the nervous systemKCT0000847Soon Chun Hyang University Hospital Bucheon516
Not yet recruiting
Not Applicable
Cerebrospinal Fluid Analysis in Psychiatry - Multicentric, prospective patient registry for cerebrospinal fluid analysis in psychiatric patientsICD-10 F*: Mental and behavioral disordersincl. planned lumbar punctureICD-10patients who receive a lumbar puncture as part of a neurological exclusion diagnosisDRKS00024041Klinik für Psychiatrie, Sozialpsychiatrie und Psychotherapie, Medizinische Hochschule Hannover200
Completed
Not Applicable
Plasma and cerebrospinal fluid concentrations treated with daily dose and high dose weekly erlotinib in non-small cell lung cancer patients with central nervous system metastasescentral nervous system metastases of non-small cell lung cancer with active EGFR mutations treated with daily dosing erlotinibJPRN-UMIN000004703Osaka City University10
Completed
Phase 4
Comparative plasma and cerebrospinal fluid pharmacokinetics of paracetamol following intravenous and oral administratioACTRN12615000322538Royal Melbourne Hospital21
Completed
Not Applicable
An observational study of serum and cerebrospinal fluid concentrations of osimertinib for the treatment of lung cancer harboring EGFR activating and T790M mutations.ung CancerJPRN-UMIN000024327Miyagi Cancer Center40